WASHINGTON -- June 20, 2012 -- The U.S. House of Representatives today is scheduled to consider legislation that would work to combat future drug shortages, maintain patient access to critical pain medications, and strengthen the patient voice as part of an effort to reauthorize and expand the industry-supported user fee